Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 495

1.

Hand Function Deficiency in Patients with Dupuytren's Disease and Course of Recovery after Palmar Fasciectomy.

Trybus M, Koziej M, Bednarek M, Brudnicki J, Pokrowiecki W.

Acta Chir Orthop Traumatol Cech. 2019;86(3):193-198.

PMID:
31333183
2.

Prospective observation of Clostridium histolyticum collagenase for the treatment of Dupuytren's disease in 788 patients: the Austrian register.

Rohit A, Peter A, Paul A, Anja B, Christian D, Renate D, Stefan G, Dietmar H, Johannes J, Peter K, Marco K, Martin L, Maximilian N, Christoph P, Gernot S, Gerald S, Tobias S, Matthias W, Armin Z, Markus G.

Arch Orthop Trauma Surg. 2019 Sep;139(9):1315-1321. doi: 10.1007/s00402-019-03226-3. Epub 2019 Jul 17.

3.

[Hyperspectral imaging demonstrates microcirculatory effects of postoperative exercise therapy in Dupuytren's disease].

Langner I, Sicher C, von Podewils S, Henning E, Kim S, Daeschlein G.

Handchir Mikrochir Plast Chir. 2019 Jun;51(3):171-176. doi: 10.1055/a-0916-8635. Epub 2019 Jun 5. German.

PMID:
31167277
4.

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.

Major M, Freund MK, Burch KS, Mancuso N, Ng M, Furniss D, Pasaniuc B, Ophoff RA.

Genet Epidemiol. 2019 Sep;43(6):629-645. doi: 10.1002/gepi.22209. Epub 2019 May 13.

5.

Reply: Surgeon Volume and the Outcomes of Dupuytren's Surgery: Results from a Dutch Multicenter Study.

Zhou C, Ceyisakar IE, Hovius SER, Feitz R, Slijper HP, Lingsma HF, Selles RW.

Plast Reconstr Surg. 2019 May;143(5):1126e-1127e. doi: 10.1097/PRS.0000000000005546. No abstract available.

PMID:
31033846
6.

Surgeon Volume and the Outcomes of Dupuytren's Surgery: Results from a Dutch Multicenter Study.

Boriani F, Raposio E.

Plast Reconstr Surg. 2019 May;143(5):1125e-1126e. doi: 10.1097/PRS.0000000000005545. No abstract available.

PMID:
31033845
7.

Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.

Zhou C, Zeldin Y, Baratz ME, Kathju S, Satish L.

BMC Musculoskelet Disord. 2019 Mar 30;20(1):135. doi: 10.1186/s12891-019-2486-3.

8.

Percutaneous needle aponeurotomy for the treatment of Dupuytren's contracture.

Karakaplan M, Ertem K, Polat H, Sakçı MŞ, Oklu Y.

Eklem Hastalik Cerrahisi. 2019 Apr;30(1):53-60. doi: 10.5606/ehc.2019.58854.

9.

Phalangeal fracture leading to digital amputation, sustained during manipulation for Dupuytren's disease as part of clostridial collagenase treatment.

Richards K, Sethu C, Tiernan E.

Ann R Coll Surg Engl. 2019 Apr;101(4):e102-e104. doi: 10.1308/rcsann.2019.0019. Epub 2019 Mar 11.

PMID:
30855178
10.

[Long-term experience with Collagenase Clostridium Histolyticum (CCH, Xiapex®) for the treatment of Dupuytren's contracture: lessons learned].

Neuwirth M, Kalt L, Pipam W, Rab M.

Handchir Mikrochir Plast Chir. 2019 Feb;51(1):38-44. doi: 10.1055/a-0832-2254. Epub 2019 Mar 5. German.

PMID:
30836418
11.

Could coenzyme Q10 be the treatment for Dupuytren's disease?

Lourens W.

BMJ Case Rep. 2019 Mar 1;12(3). pii: e226419. doi: 10.1136/bcr-2018-226419.

PMID:
30826776
12.

Echogenicity of Palmar Dupuytren's Nodules Is Not a Predictor of Disease Progression in Terms of Increase in Nodule Size.

Molenkamp S, Broekstra DC, Werker PMN.

Plast Reconstr Surg. 2019 Mar;143(3):814-820. doi: 10.1097/PRS.0000000000005340.

PMID:
30817655
13.

Current Smoking Is Associated with Delayed Wound Healing But Not with Improvement of Contracture after the Open Palm Technique for Dupuytren's Disease.

Sakai A, Zenke Y, Menuki K, Yamanaka Y, Tajima T, Uchida S.

J Hand Surg Asian Pac Vol. 2019 Mar;24(1):65-71. doi: 10.1142/S2424835519500127.

PMID:
30760148
14.

Dermoid Inclusion Cyst Following Percutaneous Needle Fasciotomy: A Novel Complication.

Reid J, Baker J, Davidson D.

J Hand Surg Asian Pac Vol. 2019 Mar;24(1):116-117. doi: 10.1142/S242483551972007X.

PMID:
30760145
15.

Clostridium histolyticum as first-line treatment of Dupuytren's disease.

Hartig-Andreasen C, Schroll L, Lange J.

Dan Med J. 2019 Feb;66(2). pii: A5527.

PMID:
30722822
16.

Universal Measures of Support Are Needed: A Cross-Sectional Study of Health Literacy in Patients with Dupuytren's Disease.

Roy M, Okrainec K, Novak CB, von Schroeder HP, Urbach DR, McCabe SJ.

Plast Reconstr Surg. 2019 Feb;143(2):350e-358e. doi: 10.1097/PRS.0000000000005209.

PMID:
30688895
17.

A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren's Disease.

Riesmeijer SA, Manley OWG, Ng M, Nolte IM, Broekstra DC, Werker PMN, Furniss D.

Plast Reconstr Surg. 2019 Feb;143(2):512-518. doi: 10.1097/PRS.0000000000005208.

18.

Collagenase Clostridium Histolyticum for Dupuytren's Contracture: Comparing Single and Concurrent Injections.

Cook J, Waughtel J, Andreoni AR, Sakharpe A, Friedman DW.

Plast Reconstr Surg. 2019 Apr;143(4):782e-787e. doi: 10.1097/PRS.0000000000005443.

PMID:
30676501
19.

Factors predicting the 1-year outcome of collagenase treatment for Dupuytren's disease.

Scheibler AG, Marks M, Hensler S, Herren DB, Calcagni M.

Arch Orthop Trauma Surg. 2019 Apr;139(4):583-588. doi: 10.1007/s00402-019-03120-y. Epub 2019 Jan 23.

PMID:
30673868
20.

Blue light irradiation and its beneficial effect on Dupuytren's fibroblasts.

Krassovka J, Borgschulze A, Sahlender B, Lögters T, Windolf J, Grotheer V.

PLoS One. 2019 Jan 11;14(1):e0209833. doi: 10.1371/journal.pone.0209833. eCollection 2019.

Supplemental Content

Loading ...
Support Center